Peloton Therapeutics, Inc. will look for acquisitions. Peloton Therapeutics is offering $115,000,000 Common Stock, $0.0001 par value per share. As of the date of this prospectus, it cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the amounts that it will actually spend on the uses. It believes opportunities may exist from time to time to expand current business through license or acquisitions of, or investments in, complementary businesses, products or technologies. While it has no current agreements, commitments or understandings for any specific licenses, acquisitions or investments at this time, we may use a portion of the net proceeds for these purposes.